SANGUINE DIAGNOSTICS AND THERAPEUTICS: Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer

SANGUINE DIAGNOSTICS AND THERAPEUTICS (Omaha, Nebraska): Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer. Its award of $399,999 is below the median of $407,048 (49th percentile). Dated 49 days ago, it serves as a historical benchmark. Score 40/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

award: $399,999 · 49th percentile of 10,712 NihBiotechGrantPulse records · 1.0x the median

Free preview: all 10 published fields of this record are shown below. Locked: 49 related NE NihBiotechGrantPulse records and the 5-column CSV export.

FieldValue
OrganizationSANGUINE DIAGNOSTICS AND THERAPEUTICS
LocationOMAHA, NE
ProjectAnti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer
Project number1R44CA306744-01A1
MechanismR44
InstituteNational Cancer Institute
Award$399,999
Awarded2026-09-16
Project period2026-09-15 to 2027-08-31
UEIECGMLSHGH4X6
award percentile49th of 10,712 (median $407,048, 1.0x median)
Peer records CSV (50 NE records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch SANGUINE DIAGNOSTICS AND THERAPEUTICS

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of NE records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock SANGUINE DIAGNOSTICS AND THERAPEUTICS + all 50 NE records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL

  • Source agency: NIH RePORTER (newly awarded projects)
  • Record date: 2026-09-16
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all NE records free →

Top NihBiotechGrantPulse records (NE first): UNIVERSITY OF NEBRASKA MEDICAL CENTER · FAMILY ROOM LLC · FATHER FLANAGAN'S BOYS' HOME · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · MASSACHUSETTS GENERAL HOSPITAL · Browse all by state and category →

LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: SANGUINE DIAGNOSTICS AND THERAPEUTICS and 50 Nebraska peers

  • Nebraska NihBiotechGrantPulse records like this one: 50
  • SANGUINE DIAGNOSTICS AND THERAPEUTICS's award: 49th percentile of 10,712 records
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every Nebraska peer: $10,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more NihBiotechGrantPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

40 / 100 Lab Budget Score

  • Award of $399,999.
  • Research or center grant: supplies, instruments and services budget.

What is the NihBiotechGrantPulse record for SANGUINE DIAGNOSTICS AND THERAPEUTICS in Omaha, Nebraska?

SANGUINE DIAGNOSTICS AND THERAPEUTICS received an NIH award of $399,999 on 2026-09-16: Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer.

How does SANGUINE DIAGNOSTICS AND THERAPEUTICS compare to other Nebraska NihBiotechGrantPulse records?

Its award of $399,999 is below the median (49th percentile); smaller records often move faster and face less competition. It is 49 days old; check the official source for later updates before acting.

SANGUINE DIAGNOSTICS AND THERAPEUTICS vs. top 3 peers

OrganizationLocationAmountPercentileRecord date
SANGUINE DIAGNOSTICS AND THERAPEUTICSOMAHA, NE399,99949th2026-09-16
UNIVERSITY OF NEBRASKA MEDICAL CENTEROMAHA, NE550,01463rd2026-09-14
UNIVERSITY OF NEBRASKA MEDICAL CENTEROMAHA, NE597,29066th2026-09-04
FATHER FLANAGAN'S BOYS' HOMEBOYS TOWN, NE612,73167th2026-09-11

Related records

NihBiotechGrantPulse: records in Nebraska NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)

More Nebraska public-record feeds

New SBA 7(a) & 504 Loan Approvals in Nebraska Bank Branch Openings, Closings & Mergers by State in Nebraska New & Re-Approved E-Rate Service Providers (FCC Form 498 / SPIN) in Nebraska Federal Alcohol Permit Holder Directory in Nebraska Carrier Out-of-Service Alerts in Nebraska Largest U.S. Greenhouse Gas Emitters by Company, Sector & State (EPA GHGRP) in Nebraska Nursing Home Inspection Deficiencies by State & Severity in Nebraska New Trucking Company Registrations in Nebraska

How to monitor SANGUINE DIAGNOSTICS AND THERAPEUTICS and peer small business sbir/sttr (r41-r44, u43-u44) records

Get new NihBiotechGrantPulse records like SANGUINE DIAGNOSTICS AND THERAPEUTICS by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together